0.65% -0.08

Atara Biotherapeutics Inc (ATRA)

Overview News Price History Option Chain Financials Why ATRA Down? Discussions Forecast

Atara Biotherapeutics Inc Stock (ATRA) Financials Data

*All numbers in millions

Period End Date	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	543.39% 27.36	4.252	2.138	0.957	1.226
Operating Expenses	8.74% 58.60	64.21	71.75	72.37	76.24
Interest Income/Expense	1.96% 1.153	1.176	1.395	1.378	1.336
Benefits Costs and Expenses	8.67% 59.09	64.69	71.95	72.06	75.97
Costs And Expenses	8.74% 58.60	64.21	71.75	72.06	75.97
Depreciation and Amortization	15.44% 1.391	1.205	1.209	1.201	1.214
Operating Income/Loss	47.89% -31.25	-59.96	-69.61	-71.41	-75.02
Income/Loss From Continuing Operations Before Tax	47.50% -31.73	-60.44	-69.82	-71.11	-74.75
Income Tax Expense/Benefit	118.18% 0.024	0.011	-0.019	0.001	0.022
Income/Loss From Continuing Operations After Tax	47.47% -31.75	-60.45	-69.80	-71.11	-74.77
Net Income/Loss	47.47% -31.75	-60.45	-69.80	-71.11	-74.77
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	18,670% 140.59	0.749	106.40	105.09	103.97
Diluted Average Shares	18,670% 140.59	0.749	106.40	105.09	103.97
Basic Earnings Per Share	58.93% -0.23	-0.56	-0.66	-0.68	-0.72
Diluted Earnings Per Share	58.93% -0.23	-0.56	-0.66	-0.68	-0.72
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.94

1.35%

INCY

$75.45

0.87%

MRNA

$43.39

3.19%

UTHR

$378.13

0.30%

BGNE

$206.16

7.31%

BNTX

$120.72

1.84%